Adia Nutrition renamed to Adia Med
Analysis based on 8 articles · First reported Jul 07, 2026 · Last updated Jul 09, 2026
The name change is a minor corporate event with limited market impact. It may slightly improve brand recognition for Adia Med Inc. among investors focused on regenerative medicine.
Adia Nutrition Inc. (OTCQB: ADIA) has completed its corporate name change to Adia Med Inc. after FINRA approved the change on an expedited timeline. The name change was reflected on the FINRA Daily List on July 9, 2026, with trading under the new name expected to begin on July 10, 2026. The company, based in Winter Park, Florida, specializes in stem cell and regenerative therapies, and the rebranding aligns its corporate identity with its healthcare mission. CEO Larry Powalisz expressed gratitude to VStock Transfer and FINRA for facilitating the transition.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard